EN
中文
Home
About us
About us
Board of Directors
Management Team
R&D and Manufacturing
Pipeline
Manufacturing Facility
Research and Development Capabilities
Strategic Partnerships
Investor Relations
Corporate Information
Announcements and Circulars
Financial Reports
Corporate Presentations
Corporate Governance
Investor Relations Contacts
News
Contact us
EN
中文
Home
About us
About us
Board of Directors
Management Team
R&D and Manufacturing
Pipeline
Manufacturing Facility
Research and Development Capabilities
Strategic Partnerships
Investor Relations
Corporate Information
Announcements and Circulars
Financial Reports
Corporate Presentations
Corporate Governance
Investor Relations Contacts
News
Contact us
From
To
Search
2024
2023
2024
全部
TOTAL:64 NEWS
Podcast Series Episode 3: Zhaoke Ophthalmology 2021 Interim Results
read
2021-08-24
2508
Zhaoke Ophthalmology’s Phase III Clinical Trial of Cyclosporine A (CsA) Ophthalmic Gel for Dry Eye Disease Meets Primary Endpoint
read
2021-08-18
1919
Zhaoke Ophthalmology Announces First Interim Results
read
2021-08-16
2555
NTC010 Approved by The Hainan Provincial Medical Products Administration for the Import as an Urgently Needed Drug
read
2021-08-02
1618
Podcast Series Episode 2: Dry Eye Disease prevalence in China and Zhaoke’s potential treatment solution
read
2021-07-30
1998
>
首页
9
10
11
12
13
尾页
Guangzhou Headquarters
Tel: 020-39062828
E-mail: info@zkoph.com
Add: No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangzhou
Hong Kong Headquarters
Tel: (852)23145100
E-mail: info@zkoph.com
Add: Unit 716, 7/F, Building 12W Phase 3, Hong Kong Science Park Shatin, Hong Kong
粤公网安备 44011502000975号
粤ICP备2022095718号
Wechat
Guangzhou Headquarters
Tel: 020-39062888
E-mail: info@zkoph.com
Add: No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangzhou
Hong Kong Headquarters
Tel: (852)23145100
E-mail: info@zkoph.com
Add: Unit 716, 7/F, Building 12W Phase 3, Hong Kong Science Park Shatin, Hong Kong
粤公网安备 44011502000975号
粤ICP备2022095718号
Wechat
